Literature DB >> 33420960

Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients.

T Apaydın1, D G Yavuz2.   

Abstract

PURPOSE: Hypercortisolism has detrimental effects on bone metabolism with the consequences of bone loss and bone fractures. We aimed to evaluate the frequency of vertebral fragility fractures and to determine the factors associated with Cushing's syndrome (CS).
METHODS: A total of 135 patients diagnosed with Cushing's syndrome [108 patients with Cushing's disease and 27 patients with adrenocortical adenoma] and 107 healthy controls were included in this cross-sectional study. The available clinical, laboratory, and radiologic data of patients with CS were recorded, retrospectively. Lateral vertebral radiograms were evaluated for vertebral fragility fractures according to Genant's semi-quantitative method. Bone mineral density (BMD) was determined using a Dual-energy X-ray absorptiometry (DEXA).
RESULTS: Vertebral fragility fractures (VFs) were observed in 75.3% (n = 61) of the patients. The median number of VFs was six (min-max: 2-12). All patients with vertebral fractures had thoracic VF, and 50.7% of the patients had lumbar fragility fractures. Thirty-three (40.7%) patients with vertebral fractures had normal bone densitometry values. Osteoporosis and osteopenia were observed in 16.2% and 40.7% of the patients, respectively. The duration of active disease, the presence of ACTH-secreting pituitary adenoma, and 24-h urinary cortisol did not influence the presence of vertebral fractures. Vertebral fractures were independently associated with age, FSH, LH levels, and lumbar BMD (R2 = 68.18%, p = 0.028). The femoral neck BMD (but not lumbar BMD) was independently associated with age, BMI, and PTH levels (R2 = 48.48%, p < 0.001).
CONCLUSION: Vertebral fracture frequency was higher in CS patients. Most of the patients with vertebral fractures had multiple fractures. Although low lumbar BMD was associated with VF, patients with CS with normal bone densitometry could experience VF. Vertebral radiograph evaluations as a part of routine evaluation for silent vertebral fractures may help to prevent further fractures in patients with CS.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Bone loss; Cushing syndrome; Osteoporosis; Pathologic fractures

Mesh:

Substances:

Year:  2021        PMID: 33420960     DOI: 10.1007/s40618-020-01496-y

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

Review 1.  Osteoporosis in Cushing's syndrome.

Authors:  Gregory Kaltsas; Luca Manetti; Ashley B Grossman
Journal:  Front Horm Res       Date:  2002       Impact factor: 2.606

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants.

Authors:  L Trementino; G Appolloni; L Ceccoli; G Marcelli; C Concettoni; M Boscaro; G Arnaldi
Journal:  Osteoporos Int       Date:  2013-10-15       Impact factor: 4.507

4.  Increased risk of osteoporotic fractures in patients with Cushing's syndrome.

Authors:  Peter Vestergaard; Jørgen Lindholm; Jens Otto L Jørgensen; Claus Hagen; Hans Christian Hoeck; Peter Laurberg; Lars Rejnmark; Kim Brixen; Lars Ø Kristensen; Ulla Feldt-Rasmussen; Leif Mosekilde
Journal:  Eur J Endocrinol       Date:  2002-01       Impact factor: 6.664

5.  Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.

Authors:  Libuse Tauchmanovà; Rosario Pivonello; Maria Cristina De Martino; Andrea Rusciano; Monica De Leo; Carlo Ruosi; Ciro Mainolfi; Gaetano Lombardi; Marco Salvatore; Annamaria Colao
Journal:  Eur J Endocrinol       Date:  2007-09       Impact factor: 6.664

6.  Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome.

Authors:  Nariko Ohmori; Kaoru Nomura; Kazue Ohmori; Yoshiharu Kato; Tatsuo Itoh; Kazue Takano
Journal:  Endocr J       Date:  2003-02       Impact factor: 2.349

7.  The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing's syndrome.

Authors:  Zhanna E Belaya; Didier Hans; Liudmila Y Rozhinskaya; Natalia V Dragunova; Natalia I Sasonova; Alexander G Solodovnikov; Timur T Tsoriev; Larisa K Dzeranova; Galina A Melnichenko; Ivan I Dedov
Journal:  Arch Osteoporos       Date:  2015-11-25       Impact factor: 2.617

8.  Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status.

Authors:  Libuse Tauchmanovà; Rosario Pivonello; Carolina Di Somma; Riccardo Rossi; Maria Cristina De Martino; Luigi Camera; Michele Klain; Marco Salvatore; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

9.  Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome.

Authors:  L Füto; J Toke; A Patócs; A Szappanos; I Varga; E Gláz; Z Tulassay; K Rácz; M Tóth
Journal:  Osteoporos Int       Date:  2007-11-28       Impact factor: 4.507

10.  Bone Health in Patients with Cushing's Syndrome.

Authors:  Sk Hammadur Rahaman; Viveka P Jyotsna; Devasenathipathy Kandasamy; V Shreenivas; Nandita Gupta; Nikhil Tandon
Journal:  Indian J Endocrinol Metab       Date:  2018 Nov-Dec
View more
  1 in total

Review 1.  Novel approaches to bone comorbidity in Cushing's disease: an update.

Authors:  Stefano Frara; Luigi di Filippo; Mauro Doga; Paola Loli; Felipe F Casanueva; Andrea Giustina
Journal:  Pituitary       Date:  2022-07-18       Impact factor: 3.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.